Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3676863019 | Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3676864013 | Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
46612001000001114 | Atenolol 25mg / Bendroflumethiazide 1.25mg capsules | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Is a | Product containing atenolol and bendroflumethiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has active ingredient | Atenolol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has active ingredient | Bendroflumethiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Is a | Product containing atenolol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has active ingredient | Bendroflumethiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has basis of strength substance | Bendroflumethiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 1.25 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has active ingredient | Atenolol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has basis of strength substance | Atenolol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has basis of strength substance | Atenolol | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has basis of strength substance | Bendroflumethiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 1.25 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Is a | Product containing atenolol and bendroflumethiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has precise active ingredient | Bendroflumethiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has precise active ingredient | Atenolol | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Is a | Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Plays role | Diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has active ingredient | Atenolol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has active ingredient | Bendroflumethiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | capsule.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has active ingredient | Bendroflumethiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Is a | Atenolol + Bendroflumethiazide | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has specific active ingredient | Atenolol | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has specific active ingredient | Bendroflumethiazide | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has dispensed dose form | Capsule | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Atenolol+bendrofluazide 25mg/1.25mg capsule - product | Is a | False | Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
Tenben 25mg/1.25mg capsules (Galen Ltd) | Is a | True | Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
Atenolol 25mg / Bendroflumethiazide 1.25mg capsules 56 capsule | Is pack of | False | Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier | |
Atenolol 25mg / Bendroflumethiazide 1.25mg capsules 56 capsule | Has VMP | True | Product containing precisely atenolol 25 milligram and bendroflumethiazide 1.25 milligram/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets